Pulsioximetría: papel en el paciente COVID-19 domiciliario

COVID-19 behaves like a heterogeneous disease. Some patients may develop dyspnea-free hypoxemia during its evolution (silent hypoxemia). Pulse oximetry plays a crucial role in detecting hypoxemia in these patients, especially when they remain at home. Patients with SpO(2) levels ≤ 92% or desaturatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Serrano-Cumplido, A., Trillo Calvo, E., García Matarín, L., del Río Herrero, A., Gamir Ruiz, F.J., Molina Escribano, F., Velilla Zancada, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedad Española de Médicos de Atención Primaria (SEMERGEN). Published by Elsevier España, S.L.U. 2022
Materias:
Revisión
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057732/
https://www.ncbi.nlm.nih.gov/pubmed/33947594
http://dx.doi.org/10.1016/j.semerg.2021.03.004
Descripción
Sumario:COVID-19 behaves like a heterogeneous disease. Some patients may develop dyspnea-free hypoxemia during its evolution (silent hypoxemia). Pulse oximetry plays a crucial role in detecting hypoxemia in these patients, especially when they remain at home. Patients with SpO(2) levels ≤ 92% or desaturations ≥ 3% after exercise test require hospital admission. Progressive saturation declines reaching SpO(2) levels < 96% require strict clinical assessment (radiological study, blood test) for which it will be sent to a health center.

Ejemplares similares